Literature DB >> 24851699

Epigenetics and epilepsy.

L Pulido Fontes1, P Quesada Jimenez2, M Mendioroz Iriarte3.   

Abstract

INTRODUCTION: Epigenetics is the study of heritable modifications in gene expression that do not change the DNA nucleotide sequence. Some of the most thoroughly studied epigenetic mechanisms at present are DNA methylation, post-transcriptional modifications of histones, and the effect of non-coding RNA molecules. Gene expression is regulated by means of these mechanisms and disruption of these molecular pathways may elicit development of diseases. DEVELOPMENT: We describe the main epigenetic regulatory mechanisms and review the most recent literature about epigenetic mechanisms and how those mechanisms are involved in different epileptic syndromes.
CONCLUSION: Identifying the epigenetic mechanisms involved in epilepsy is a promising line of research that will deliver more in-depth knowledge of epilepsy pathophysiology and treatments.
Copyright © 2014 Sociedad Española de Neurología. Published by Elsevier Espana. All rights reserved.

Entities:  

Keywords:  Epigenetics; Epigenética; Epilepsia; Epilepsy; Epileptogenesis; Epileptogénesis; Neurodesarrollo; Neurodevelopment

Mesh:

Substances:

Year:  2014        PMID: 24851699     DOI: 10.1016/j.nrl.2014.03.012

Source DB:  PubMed          Journal:  Neurologia        ISSN: 0213-4853            Impact factor:   3.109


  8 in total

1.  Global DNA methylation analysis reveals miR-214-3p contributes to cisplatin resistance in pediatric intracranial nongerminomatous malignant germ cell tumors.

Authors:  Tsung-Han Hsieh; Yun-Ru Liu; Ting-Yu Chang; Muh-Lii Liang; Hsin-Hung Chen; Hsei-Wei Wang; Yun Yen; Tai-Tong Wong
Journal:  Neuro Oncol       Date:  2018-03-27       Impact factor: 12.300

Review 2.  Epigenetics and epilepsy prevention: The therapeutic potential of adenosine and metabolic therapies.

Authors:  Detlev Boison; Jong M Rho
Journal:  Neuropharmacology       Date:  2019-08-13       Impact factor: 5.250

Review 3.  The Promising Epigenetic Regulators for Refractory Epilepsy: An Adventurous Road Ahead.

Authors:  Vemparthan Suvekbala; Haribaskar Ramachandran; Alaguraj Veluchamy; Mariano A Bruno Mascarenhas; Tharmarajan Ramprasath; M K C Nair; Venkata Naga Srikanth Garikipati; Rohit Gundamaraju; Ramasamy Subbiah
Journal:  Neuromolecular Med       Date:  2022-09-24       Impact factor: 4.103

Review 4.  Genetic susceptibility in Juvenile Myoclonic Epilepsy: Systematic review of genetic association studies.

Authors:  Bruna Priscila Dos Santos; Chiara Rachel Maciel Marinho; Thalita Ewellyn Batista Sales Marques; Layanne Kelly Gomes Angelo; Maísa Vieira da Silva Malta; Marcelo Duzzioni; Olagide Wagner de Castro; João Pereira Leite; Fabiano Timbó Barbosa; Daniel Leite Góes Gitaí
Journal:  PLoS One       Date:  2017-06-21       Impact factor: 3.240

5.  Length Polymorphism and Methylation Status of UPS29 Minisatellite of the ACAP3 Gene as Molecular Biomarker of Epilepsy. Sex Differences in Seizure Types and Symptoms.

Authors:  Irina O Suchkova; Elena V Borisova; Eugene L Patkin
Journal:  Int J Mol Sci       Date:  2020-12-02       Impact factor: 5.923

Review 6.  Genetic and epigenetic mechanisms of epilepsy: a review.

Authors:  Tian Chen; Mohan Giri; Zhenyi Xia; Yadu Nanda Subedi; Yan Li
Journal:  Neuropsychiatr Dis Treat       Date:  2017-07-13       Impact factor: 2.570

7.  microRNA-139-5p confers sensitivity to antiepileptic drugs in refractory epilepsy by inhibition of MRP1.

Authors:  Li Wang; Lifang Song; Xiaoyi Chen; Junfang Suo; Yanli Ma; Jinghe Shi; Kai Liu; Guohong Chen
Journal:  CNS Neurosci Ther       Date:  2019-11-21       Impact factor: 5.243

Review 8.  Expression Profile of miRs in Mesial Temporal Lobe Epilepsy: Systematic Review.

Authors:  Kristina D Yakovleva; Diana V Dmitrenko; Iulia S Panina; Anna A Usoltseva; Kirill A Gazenkampf; Olga V Konovalenko; Elena A Kantimirova; Maxim A Novitsky; Regina F Nasyrova; Natalia A Shnayder
Journal:  Int J Mol Sci       Date:  2022-01-16       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.